PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 73: Articles 36001-36500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Mechanisms involved in progesterone contraception and estrogen interception.
  2. Mechanisms of carbohydrate intolerance in oral contraceptive therapy.
  3. Medical and behavioral perspectives on family planning services.
  4. The medical faculty courses on contraceptive techniques and problems of living together. [Det medisinske fakultets kurs om prevensjonsveiledning og samlivsproblemer.]
  5. The medical school course on contraception and family problems. The ideological manipulation of sexual pedagogy. [Det medisinske fakultets kurs om prevensjonsveiledning og samlivsproblemer.]
  6. Medroxyprogesterone acetate administered intramuscularly every third month as a contraceptive. An investigation of the efficacy, side effects, and acceptability. [Medroksyprogesteronacetat som kontraceptivum givet som i.m. injection hver 3. moned. En undersogelse af effektivitet, bivirkninger og accept abilitet.]
  7. Medroxyprogesterone acetate as a contraceptive. [Medroksyprogesteronacetat som kontraception.]
  8. Medroxyprogesterone acetate as an injectable contraceptive - its utility in Indian women.
  9. Medroxyprogesterone acetate injectable contraceptive: proposed patient labeling.
  10. Meeting on Family Planning Manpower in Less Developed Countries, Rosslyn, Virginia, November 22, 1972]. Summary.
  11. Megaloblastic changes in the cervical epithelium: association with oral contraceptive therapy and reversal with folic acid.
  12. Menstrual regulation in family planning services.
  13. Mesenteric venous thrombosis in 2 women taking oral contraceptives.
  14. Metabolic changes due to hormonal contraceptives. [Stoffwechselveranderungen durch hormonale Kontrazeptiva.]
  15. Metabolic effects of contraceptive steroids.
  16. Metabolic effects of oral contraceptives in monkeys fed adequate protein and low protein diets.
  17. Metabolic effects of oral contraceptives on the liver - bile secretory failure.
  18. Metabolic effects of oral contraceptives.
  19. Metabolic fate of a long-acting injectable estrogen-progestogen contraceptive.
  20. Metabolic side-effects of oral contraceptives.
  21. Metabolism of glucose in the human endometrium with special reference to fertility and contraception.
  22. Metallic copper as an intrauterine contraceptive agent.
  23. A method for estimating future caseload of family planning programs.
  24. The methodology of research in family planning.
  25. Mini-manual for use of DMPA as an injectable contraceptive.
  26. Minnesota: PP unit may continue to provide contraceptives to most minors.
  27. Missed appointments at a family planning clinic.
  28. Mode of action of steroidal contraceptives.
  29. Model neighborhood family planning program.
  30. Modern birth control methods.
  31. Nonclinical distribution of oral contraceptives.
  32. Nonphysician professionals being trained to provide medical family planning care.
  33. Nonprocreative sexuality as an alternative to contraception.
  34. Noriday: a new advance in oral contraception. (Advertisement)
  35. Norigest injectable contraceptive. (Informational material)
  36. Norigest: injectable contraceptive.
  37. A note on the assets and difficulties of Egypt's family planning program.
  38. Note on the national family planning program in Costa Rica.
  39. A note on the susceptibility of N. gonorrhoeae to contraceptive agent Nonyl-P.
  40. Nucleic acid of the mucus cells of the body of the uterus in females during the course of the menstrual cycle while under the use of oral contraceptives. [Kwasy nukleinowe komorek blony sluzowej trzonu macicy kobiet w przebiegu cyklu miesiaczkowego indukowanego doustnymi srodkami antykoncepcynjymi.]
  41. Number of pregnancies, use of oral contraceptives and menopausal age in women with ischaemic heart disease, compared to a population sample of women.
  42. Numerator analysis of fertility and family planning in Maryland.
  43. Nurses and family planning.
  44. Nurses and midwives in family planning.
  45. Nutrition and family planning.
  46. Observations on abortion and family planning in Latin America: notes on a 1973 visit to Caracas, Santiago, and Mexico City, January 20-February 3, 1973.
  47. Observations on evaluation of family planning programs.
  48. Ocular side-effects of oral contraceptives.
  49. Offering contraceptive kits to newlyweds. Study 79.
  50. Old methods of birth control in the frontier province.
  51. On applying marketing models to the family planning process.
  52. On measurement of overall impact of family planning programme on fertility reduction.
  53. On the changing morphological appearance of endometriosis: unusual occurrences of retrogression in pseudogravida retrocervical endometriosis caused by oral contraceptives. [Zum wechselnden morphologischen Erscheinungsbild der Endometriose.]
  54. On the effect of the family planning programme on the birthrate in Kerala.
  55. On the mechanism of the contraceptive effect of estrogens administered after ovulation. [K mechanismu antikoncepcniho ucinku estrogenu podanych po ovulaci.]
  56. On the mini-pill. Toward an understanding of its mode of action in contraception. [A propos de la Mini-Pill. Essai de comprehension de son mecanisme d'action contraceptive.]
  57. One-hour glucose tolerance in relation to the use of contraceptive drugs.
  58. One-year contraceptive follow-up of adolescent patients.
  59. Operational evaluation of family planning programs through process analysis.
  60. Ophthalmological complications following oral contraception. [Opthalmologische Komplikationen nach oraler Kontrazeption.]
  61. Optimization of sequential contraceptive therapy through shortening of estrogen phase. [Ueber die Optimierung der kontrazeptive genutzten Sequentialbehandlung durch Verkuerzung der Oestrogenphase.]
  62. Oral contraception and coagulation. [Contraception orale et coagulation.]
  63. Oral contraception and increased risk of cerebral ischemia or thrombosis.
  64. Oral contraception and lipid metabolism. [Orale Kontrazeption und Lipoidstoffwechsel.]
  65. Oral contraception and liver function. [Oral antikonsepsjon og leverfunksjon.]
  66. Oral contraception supresses gonadotrophin release induced by synthetic LH and FSH-releasing hormone (RH). (Abstract only)
  67. Oral Contraception with progestin alone. (Advertisement)
  68. Oral contraception.
  69. Oral contraception.
  70. Oral contraception: 40 years of development.
  71. Oral contraceptive - alpha-tocopherol interrelationships. (Paper presented in the symposium: Effects of Drugs on Lipid Metabolism, AOCS Spring meeting, New Orleans, April 1973.)
  72. Oral contraceptive and dermatology.
  73. Oral contraceptive continuation/discontinuation rates.
  74. Oral contraceptive effects on the breast. (Letter to the editor)
  75. Oral contraceptive therapy for severe acne in a woman.
  76. Oral contraceptive used only prior to intercourse.
  77. Oral contraceptive users' LBW (low birth weight) babies less prone to RDS (respiratory distress syndrome)
  78. The oral contraceptive.
  79. Oral contraceptive/alpha-tocopherol interrelationships.
  80. Oral contraceptive: NOR-Q.D.
  81. Oral contraceptives and birth defects: preliminary evidence for a possible association.
  82. Oral contraceptives and blood pressure.
  83. Oral contraceptives and breast histology. (Letter to the editor)
  84. Oral contraceptives and cerebrovascular disease.
  85. Oral contraceptives and folate absorption.
  86. Oral contraceptives and hypertension.
  87. Oral contraceptives and increased risk of cerebral ischemia or thrombosis: risk factors. (Abstract only)
  88. Oral contraceptives and myocardial infarction.
  89. Oral contraceptives and myocardial infarction. (Letter to the editor)
  90. Oral contraceptives and myocardial infarction. (Letter to the editor)
  91. Oral contraceptives and myocardial infarction. (Letter)
  92. Oral contraceptives and prevention of cancer of the uterus and breast.
  93. Oral contraceptives and psychiatric disturbance: evidence from research.
  94. Oral contraceptives and respiratory distress syndrome.
  95. Oral contraceptives and risk of thromboembolism. (Letter to the editor)
  96. Oral contraceptives and stroke.
  97. Oral contraceptives and the N.B.T. test.
  98. Oral contraceptives and the N.B.T. test. (Letter to the editor)
  99. Oral contraceptives and the red blood cell.
  100. Oral contraceptives and thromboembolic disease.
  101. Oral contraceptives and thromboembolism.
  102. Oral contraceptives and thrombosis/embolism. [P-pille og trombose/emboli.]
  103. Oral contraceptives and venous thromboembolic disease, surgically confirmed gall-bladder disease, and breast tumours.
  104. Oral contraceptives and venous thromboembolic disease, surgically confirmed gall-bladder disease, and breast tumours: report from the Boston Collaborative Drug Surveillance Programme.
  105. Oral contraceptives and vitamin B-6.
  106. Oral contraceptives before operation.
  107. Oral contraceptives causing porphyria cutanea tarda. [Doustne srodki antykoncepcyjne jako czynniki wywolujace pozna porfirie skorna.]
  108. Oral contraceptives on N.H.S. (National Health Service) prescription. (Letter to the editor)
  109. Oral contraceptives on the pharmaceutical benefits list. (Letter to the editor)
  110. Oral contraceptives urged without prescription. Text of a statement by the IPPF Central Medical Committee, April 1973.
  111. Oral contraceptives, pyridoxine, and depression.
  112. Oral contraceptives.
  113. Oral contraceptives.
  114. Oral contraceptives.
  115. Oral contraceptives.
  116. Oral contraceptives: a medical audit.
  117. Oral contraceptives: risks and benefits. (Letter to the editor)
  118. Oral contraceptives: risks and benefits. (Letter to the editor)
  119. Oral contraceptives: Therapeutics versus adverse reactions, with an outlook for the future I.
  120. Oral contraceptives: Therapeutics versus adverse reactions, with an outlook for the future II.
  121. Oral-contraceptives on pharmaceutical benefits list.
  122. Organization and administration of family planning programmes.
  123. Organizational behavior and its relevance for the management of family planning programs.
  124. Organized family planning programs in the United States: 1968-1972.
  125. Other contraceptive techniques: diaphragm and jelly, condom, jelly or foam alone, and rhythm.
  126. Other people's family planning: [review of The Khanna Study and The Myth of Population Control]
  127. Our experience with intrauterine contraception. [Unsere Erfahrung mit intrauteriner Kontrazeption.]
  128. Our principles in the selection of steroid contraceptives. [Nase zasady pri volbe steroidnich antikoncepcnich pripravku.]
  129. Outline of the programme on performance improvement in management of family planning and population programmes in Asia.
  130. Ovarian morphology and pituitary gonadotrophins in serum during and after long-term treatment with oral contraceptives. (Abstract only)
  131. Ovarian pregnancy with an intrauterine contraceptive device in situ: a case report.
  132. Over the green mountains: a report from East Java (Family planning program)
  133. Over-the-counter contraceptives and other vaginal drug products.
  134. Overview 1972: medical and clinical activities, family planning associations, western hemisphere region, January 1 - December 31, 1972.
  135. The ovulation method of family planning.
  136. Ovulation method of family planning. (Letter to the editor)
  137. The "ovulation method" in the framework of contraception. [Il "metodo della ovulazione" nel quadro della contraccezione.]
  138. Pancreatitis from oral contraceptives.
  139. Pancreatopathy related to oral contraceptives. [Ovulationshemmer-Pankreopathie.]
  140. Parenteral steroid contraception.
  141. Parliament: N.H.S. reorganization: contraceptives.
  142. Participation of midwives in family planning in Taiwan, the Republic of China.
  143. The participation of the TBA in maternal and child care and family planning in Costa Rica.
  144. The participation of the TBA in maternal and child care and family planning, Costa Rica.
  145. The participation of the traditional birth attendants in maternal and child care and family planning in Costa Rica.
  146. The participation of the traditional birth attendants in maternal and child care and family planning in Costa Rica.
  147. Pathology of the reproduction system, breast, and liver in women during hormonal contraception.
  148. Patient attrition in five Mexico City family planning clinics.
  149. Pattern of plasma renin activity of women taking oral contraceptives. (Abstract only)
  150. Pediatric aspects of family planning.
  151. Permanent birth control.
  152. Persistent hypercoagulability after venous mesenteric infarction and oral contraceptive.
  153. Pharmacokinetics of contraceptive steroids in humans.
  154. Pharmacology of contraceptive agents - new compounds with new problems?
  155. Pharmacology of progestational agents and oral contraceptives.
  156. Pharmacology of the contraceptive steroids.
  157. Pharmacophysiologic and clinical aspects of oral contraceptives.
  158. Philippine family planning chartbook: 1973.
  159. Philippine family planning knowledge, attitudes, and practices: baseline data, 1968: introduction and summary.
  160. The Philippine physician, population growth and family planning. [El medico filipino, el crecimiento de la poblacion y la planificacion familiar.]
  161. Physical contraceptives methods. [Les methodes physiques.]
  162. The physician and family planning. [El medico y la planificacion familiar.]
  163. The physician's influence on the nonacceptance of birth control.
  164. Physiological considerations of the normal ovarian cycle and contraception.
  165. Pituitary reserve of LH and FSH in women with amenorrhea on contraceptive therapy.
  166. The place of abortion and sterilization in the general programme of planned parenthood.
  167. The place of surgery in family planning. (Abstract only)
  168. Planned parenthood -- the challenge of the '70s.
  169. Planned Parenthood Associations: Use of media resources.
  170. Planned Parenthood services in teaching hospitals.
  171. Planning for family planning.
  172. planning, organization and management of information-education support for family planning programs.
  173. The planning-operation-evaluation cycle in family planning program administration (Central America)
  174. Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agent.
  175. Plasma-aldosterone during oral-contraceptive therapy.
  176. Pleasure and contraception. [Plaisir et contraception.]
  177. Policy guidelines for collective bargaining and family planning.
  178. Political aspects of family planning.
  179. The politics of contraception and abortion.
  180. Population and family planning: an approach to communications as a program component.
  181. Population growth and family planning.
  182. Population growth rates in perfect contraceptive populations.
  183. Population growth, contraception, and the high school student in rural Punjab.
  184. Population planning in Bangladesh: complementary roles of family planning and other development programs.
  185. Population policies affecting fertility: a sociological perspective on family planning programs.
  186. Population policy and family planning programs in Asia and the Pacific.
  187. A population programme is more than family planning.
  188. Porphyria with neuropsychiatric manifestations and contraceptive agents. [Porfiria con manifestazioni neuropsichiatriche ed inibitori dell'ovulazione.]
  189. Possible association between benign hepatomas and oral contraceptives.
  190. Possible biological effects of contraceptives. [Posibles efectos biologicos de los anticonceptivos.]
  191. Possible improvement in quality of human progeny by maternal dietary intervention: implications for programs of family planning and food production.
  192. Post-coital contraception by iodine.
  193. Post-coital contraception: review.
  194. Postcoital contraceptive effects of medroxyprogesterone acetate and oestrone in rats.
  195. Postgraduate medical education and the training of practicing physicians in family planning.
  196. Potency of progestational agents in oral contraceptives. [Gestagenpotenzen in der hormonalen Kontrazeption.]
  197. Practitioners of indigenous medicine and India's family planning programme.
  198. Pre-pregnancy oral contraception and sex ratio among subsequent progeny.
  199. Pre-pregnancy oral contraceptives and respiratory-distress syndrome.
  200. Pregnancy and contraception in adolescent girls. [Grossesse et contraception de l'adolescente.]
  201. Pregnancy and contraception in youth. [Schwangerschaft und Antikonzeption bei Jugendlichen und Heranwachsenden.]
  202. Preliminary analysis new family planning acceptors characteristics in Java and Bali through first semester 1972/1973 GOI FY (April 1-September 30, 1972)
  203. Preliminary evidence for a possible association between oral contraceptives and birth defects. (Abstract only)
  204. A preliminary survey of 16,000 teenagers entering a contraceptive program.
  205. Premature onset of menstrual bleeding during ovulatory cycles in women with an intrauterine contraceptive device.
  206. Premises of postpartum family planning. [Praemissen postpartaler Familienplanung.]
  207. Prenatal diagnosis, an essential to family planning in cases of genetic risk.
  208. Prescribing of oral contraceptives.

     

  209. Present methods and perspectives in male contraception. [Contraception masculine methodes actuelles et perspectives.]
  210. Present-day aspects of the problem of oral steroid contraception. [Sovremennie aspekty problemy oralnoi kontratseptsii.]
  211. Preventing family planning's sterilization by its own fertility.
  212. Prisoners of hope (Family planning)
  213. The private commercial distribution of contraceptives in Nicaragua: a preliminary study.
  214. Private practice experience with intrauterine contraceptive devices.
  215. Pro-con vaginal contraceptives as venereal disease prophylactic agents.
  216. Problem bleeding with intrauterine contraceptive devices.
  217. Probleme der Kontrazeption bei Adoleszenten. (Problems of contraception in adolescents.)
  218. The problems in educating and training personnel for a family planning program in a developing country.
  219. Problems in survey methodology relating to surgical contraception.
  220. Problems in the experimental design of clinical trials with oral contraceptive agents.
  221. Problems of birth control. [Probleme der Geburtenregelung.]
  222. Problems of family planning in Mexico. 3. Overpopulation and health. [3. Sobrepoblacion y salud.]
  223. Problems of family planning in Rhodesia.
  224. Problems of human communication in population and family planning work.
  225. Proceedings. Seminar on Family Planning Communication for Civic and Community Leaders. Diliman, Quezon City, 21 July 1973.
  226. Process-content-action: training family planning workers as agents of social change.
  227. Profile of the cycle and indication for hormonal contraception. (Abstract only)
  228. Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone.
  229. The program of an institute of population studies and its relationship to medical education and to a national family planning program.
  230. Program of comparative studies of abortion and contraceptive use in Latin America: Bogota, 1972. Methodology. [Programma de estudios comparativos de aborto inducido y uso de anticonceptiovs en America Latina: Bogota, 1972. Metodologia.]
  231. Program of comparative studies of induced abortion and the use of contraceptives in Latin America, Bogota, 1973: methodology. [Programa de estudios comparativos de aborto inducido y uso de anticonceptivos en America Latina, Bogota, 1973: metodologia.]
  232. Progress and developmental possibilities in pharmacological contraception. [Fortschritte und Entwicklungsmoglichkeiten in der medikamentosen Empfang nisverhutung.]
  233. Progress in endocrinology and metabolism: contraceptive steroids: modifications of carbohydrate and lipid metabolism.
  234. Prolonged-action contraceptives. Evaluation of various therapeutic methods. Experience of 8 years' use. [Anticonceptivos de deposito. Evaluacion de diversos esquemas terapeuticos. Experiencia de 8 anos de uso.]
  235. The promise of pharmacologic modification of ovum transport in contraceptive development.
  236. Prospective study of contraception in collaboration with the I.N.S.E.R.M. [L'enquete prospective sur la contraception in collaboration avec I'I.N.S.E.R.M.]
  237. Prospective study of women using different methods of contraception. (Abstract only)
  238. Protein metabolism in women using Femigen-polfa as oral contraceptives. [Gospodarka bialkowa u kobiet przyjmujacych preparat Femigan-Polfa w celach antykoncepcyjnych.]
  239. Proteinase inhibitor capacities during treatment with the oral contraceptive Ovosiston. [Proteinasen-Inhibitorkapazitaten im Serum wahrend der Einnahme des oralen Kontrazeptivums Ovosiston.]
  240. Provisional data from the national reporting system for family planning services: January 1972-December 1972.
  241. Psychiatric aspects of contraception.
  242. Psychiatric considerations in prescribing a contraceptive regimen.
  243. The psychiatrist and family planning.
  244. Psychodynamics of contraception with particular reference to rhythm.
  245. Psychological aspects of male contraception. [Aspects psychologiques de la contraception masculine.]
  246. Psychological aspects of side effects of oral contraceptives. [Psychologische Aspekte der Nebenwirkungen oraler Kontraceptiva.]
  247. Psychological changes as side effects of hormonal contraceptives. [Psychische Veranderungen als Nebenwirkungen hormoneller Kontrazeptiva.]
  248. Psychological factors, psychiatric illness and amenorrhoea after oral contraceptive treatment.
  249. Psychological perspectives: family planning in Korea. By Chung, B.M., Palmore, J.A., Lee, S.J., and Lee, S.J. (Book Review)
  250. Psychological reactions to surgical contraception.
  251. Psychosexual problems associated with the contraceptive practices of abortion-seeking patients.
  252. Psychosexual problems associated with the oral contraceptive practices of abortion-seeking patients: a commentary.
  253. Psychosexual problems associated with the oral contraceptive practices of abortion-seeking patients: a commentary.
  254. Psychosexual problems associated with the oral contraceptive practices of abortion-seeking patients: a commentary. Psychosexual problems associated with the OC practices of abortion-seeking patients.
  255. Psychosexual problems with oral contraceptive practices of abortion-seeking patients: a commentary.
  256. Psychosocial aspects of contraceptive sterilization in women.
  257. Psychosocial aspects of family planning.
  258. Psychosocial information for medical education in family planning.
  259. Public and private opinion on population and family planning.
  260. Public expenditure analysis and family planning programs.
  261. Public health and family planning: a study of inter-relationship in India.
  262. Public health aspects of surgical contraception.
  263. The public health stake in family planning health role challenged.
  264. Public opinion and family planning.
  265. Public provision of family planning information and services.
  266. Pulmonary embolism in a man taking an oral contraceptive. (Letter to the editor)
  267. Pyridoxine and depression associated with oral contraception.
  268. Quarterly summary of family planning statistics.
  269. A quest for the elusive chemical male contraceptive.
  270. Questioning some assumptions about family planning behavior, with implications for the introduction of fertility control innovations.
  271. Questions and answers about commercial resources for family planning communication programs.
  272. Radio and family planning in the Dominican Republic.
  273. Radioimmunoassay of contraceptive steroids. I. Synthesis of 6-oxomestranol 6-(0-carboxymethyl) oxime.
  274. Radiologic aids to localization of an extrauterine intrauterine contraceptive device.
  275. Rationale for the involvement of private sector marketing institutions in family planning in Africa.
  276. A reanalysis of female reactions to contraceptive sterilization.
  277. Recent advances in birth control techniques.
  278. Recent legal aspects of contraception. [Aspects legislatifs recents de la contraception.]
  279. Recommendations for family planning programs in Costa Rica. [Recomendaciones para programas de planificacion familiar in Costa Rica.]
  280. Recommendations for teaching family planning in medicine.
  281. Recommended procedures for the statistical evaluation of intrauterine contraception.
  282. Recruitment of family planning acceptors.
  283. Recruitment, training and staff development: system adopted so far in Bangladesh Family Planning Program.
  284. Reduced ascorbic-acid excretion and oral contraceptives.
  285. Reestablishment of postpartum ovulation and contraception.
  286. Reflections on family planning management and a program for improvement in Colombia, Venezuela, Central America, Mexico.
  287. Regional seminar on the medical and surgical aspects of family planning.
  288. Regulation of medical devices (intrauterine contraceptive devices)
  289. Relation between oral contraceptive agents and thyroiditis? [Zusammenhang zwischen Einnahme der "Pille" und einer Thyreoiditis?]
  290. The relationship between the level of development and family planning performance in India.
  291. The relationship of oral contraception to depressive symptoms.
  292. Relationships between governments and voluntary family planning associations.
  293. Relative estrogen deficiency due to oral contraception. [Relativer Oestrogenmangel durch Ovulationshemmer.]
  294. The relative safety of currently available contraception methods in the United States.
  295. Religious aspects of family planning. [Aspectos religiosos de planejamento familiar.]
  296. Remarks on the problem of contraception for girls vaccinated against rubella (Abstract Only) [Remarques sur le probleme de la contraception des jeunes adolescentes vassinees contre la rubeole.]
  297. Removal of ectopic intrauterine contraceptive devices aided by laparoscopy.
  298. Reorganized family planning.
  299. Reply to Cutright and Osborn. (Need for Family Planning Services)
  300. A report of an evaluation of the International Planned Parenthood Federation Programme in Botswana, 1969-1973.
  301. Report of the discussion of the symposium on contraceptive drugs.
  302. Report of the expert group on developing indices for measuring the impact of training on job performance of field workers in family planning programmes.
  303. Report of the first national survey on family planning in Singapore, 1973.
  304. Report of the survey team concerning the decrease in pill acceptors in the Philippines family planning program.
  305. Report on consultation to the social services project in family planning, department of social welfare, Philippines.
  306. A report on knowledge, attitudes and practice on fertility and family planning in Western Samoa, 15 November 1971-31 January 1972.
  307. A report on the family planning program in the People's Republic of China.
  308. Report on the labour seminar on family planning.
  309. Report on the seminar for the teaching of family planning at the Taiwan Provincial Junior College of Nursing: August-September 1970.
  310. Report on the student knowledge and attitude test on contraceptive methods for the fourth year class of the National Defense Medical Center.
  311. Report to the government of Pakistan on workers' education for family planning.
  312. Report. Regional Seminar on the Status of Women and Family Planning for Countries of the Western Hemisphere, Santo Domingo, May 9-22, 1973.
  313. Research in contraception and reproduction: a status report, 1973.
  314. Research in family planning in Alexandria.
  315. Research utilization techniques borrowed from marketing relevant to communication research in population/family planning.
  316. A researcher's guide to social-psychological-communication variables in family planning research.
  317. Resistance to contraception) [La resistance a la contraception.]
  318. Resistance to family-planning centers in the black community.
  319. Resources in review (Family planning)
  320. Response of the pituitary gland to stimulation with luteinizing hormone releasing Hormone in women with amenorrhea after cessation of contraceptive treatment.
  321. Response validity to family planning questions.
  322. Responsible paternity family planning: a thesis with social projections. [Paternidad responsable planificacion familiar: una teses de proyeccion social.]
  323. Results of contraception consultation in a university hospital clinic. [Bilan d'une consultation de contraception dans un service hospitalo-universitaire.]
  324. Results of the application of intrauterine contraceptives. [Rezultaty primeneniya vnutrimatochnykh kontratseptivov.]
  325. Results of using a low dose estrogen-progestagen mixture as a contraceptive. [Resultado del uso de una mezcla estrogeno-progestageno a dosis bajas, co mo anticonceptive.]
  326. Reversible mesenteric vascular occlusion associated with oral contraceptives.
  327. Review of research and studies on the health education and related aspects of family planning (1967-1971): communication, program planning and evaluation.
  328. A review of the current status of training evaluation at regional family planning training centres.
  329. (Review of The Korean National Family Planning Program: Population Control and Fertility Decline. T.I. KIM, J.A. ROSS, and G.C. WORTH. New York, The Population Council, 1972.)
  330. Revisits with Study 2 wives given family planning pamphlets. Study 3.
  331. The right of privacy and family planning.
  332. Role of a man in the practice and promotion of family planning.
  333. The role of ECAFE in family planning and population programmes.
  334. The role of family planning in the world population crisis.
  335. The role of family planning services.
  336. Role of histamine release - a possible mechanism of action of intrauterine contraceptive device.
  337. The role of home economics in family planning: Korea.
  338. The role of hormones in the processes of ovogenesis, ovulation, transport of gametes, and implantation from the aspect of the effect of contraceptive preparations.
  339. Role of husband in family planning behavior.
  340. The role of MCH services in family planning. Report on a conference, Ljubljana, December 4-8, 1972.
  341. Role of platelet factor 3 in the hypercoagulability induced by pregnancy and oral contraceptives.
  342. The role of progestogen potency in hormonal contraception. (Abstract only)
  343. Role of sterilization in current family-planning programs.
  344. The role of the civic and community leaders in family planning communication.
  345. Role of the hospital doctor and the general practitioner in communication in family planning in Sri Lanka and other developing countries.
  346. The role of the International Labour Organisation in family planning and population programmes.
  347. The role of the medical schools in the family planning program in Korea.
  348. The role of the village girl leaders in family planning.
  349. The role of the World Bank in family planning and population programmes.
  350. The role of the World Health Organization in health related aspects of family planning.
  351. The role of UNESCO in family planning and population programmes.
  352. The role of UNICEF in family planning and population programmes.
  353. The role of voluntary agencies in family planning.
  354. The role of voluntary agencies in national family planning programmes.
  355. Role of voluntary organisations in family planning education and services.
  356. The role of voluntary organizations in national family planning programmes: report and selected documents of the expert group on the role of voluntary organizations in national family planning programmes, Bangkok, Thailand, August 7-12, 1972.
  357. The role of WHO in family planning programmes.
  358. Roles of health professionals in family planning.
  359. Rubella vaccination in young women attending a family planning clinic.
  360. Rural health services and family planning utilization. Annual report of population research, 1972-1973.
  361. Rural Maternal/Child Health Family Planning Project, Southeastern State.
  362. Safety of contraceptives.
  363. The safety of oral contraceptives.
  364. San Juan Family Planning Services Project Annual Report 1973.
  365. Scanning electron microscopy of human uterine epithelium influenced by the TCu intrauterine contraceptive device.
  366. Scheme for expanding family planning provision.
  367. Scope of family planning programmes in the organized sector.
  368. Secondary amenorrhoea following oral contraception-causal or coincidental?
  369. Selecting the optimum oral contraceptive.
  370. Selectivity of early adopters of contraception in West Malaysia.
  371. Seminar on Maternity-Centered Family Planning, Davao, Philippines, July 11-20, 1972.
  372. Seminar-Workshop on Problems of Managing Family Planning Programs, Washington, D.C., October 8-November 16, 1973. Final report and supplements 1 and 2.
  373. Seoul's "dial-a-phone for family planning".
  374. Serious pelvic infections associated with intrauterine contraceptive device.
  375. Serum LH concentration in women under contraceptive treatment with estrogen-free progestagens.
  376. Seventh annual report of the St. Vincent Planned Parenthood Association, 1 January-31 December 1972.
  377. Sex and contraception among unmarried teenagers.
  378. Sex differentials among family planning physicians in the Philippines.
  379. Sex education and contraception.
  380. Sex-specific differences of serum-proteins in adults and influence of oral hormonal contraceptives on serum-protein composition. [Geschlechtsspezifische Unterschiede der Serumproteine bei Erwachsenen und Einfluss der oralen hormonellen Kontrazeptiva auf das Serumweissbild.]
  381. Sexual experience of younger teenage girls seeking contraceptive assistance for the first time.
  382. Sexuality, birth control and abortion: a decision-making sequence.
  383. Sexuality, contraception and pregnancy in a high-school population.
  384. A short history of contraception.
  385. A short note on the achievements in family planning in India.
  386. Short-term costs and benefits of the Federal family planning program.
  387. Sickle cell disease. The case for family planning.
  388. SIDA (Swedish International Development Authority) and contraceptives.
  389. Side effects of oral contraceptives--critique on test methods. [Nebenwirkungen oraler Kontrazeptiva: eine Kritik der Prufungsmethoden.]
  390. Side-effects from oral contraceptives. (Letter to the editor)
  391. Significance of prolong lactation as a natural method for family planning-survey of 1052 women for family planning methods.
  392. Silastic implant: a new method for birth control.
  393. A simple method of contraception with intravaginal urea solution.
  394. Simple writing, planning, development, and production of printed family planning communication materials.
  395. The Singapore National Family Planning and Population Programme, with special reference to new directions and emphasis--1973-74.
  396. Singapore: effects of a national family planning programme.
  397. Singapore: Family planning in an urban environment.
  398. Singapore: the demographic effects of a national family planning programme.
  399. Small intestinal disease, folate deficiency anemia, and oral contraceptive agents.
  400. Social and hygienic problems of hormonal contraception. 2. The place of hormonal contraception in the prophylaxis of unwanted pregnancy. [Sotsialno-khigienni problemi na khormonata antikontseptsiya. 2. Myastoto na khormonnata antikontseptsiya v profilaktikata na nezhelanata bremennost.]
  401. Social and labor laws and family planning.
  402. Social aspects of family planning.
  403. Social aspects of family planning.
  404. Social communication in family planning: a case book.
  405. Social factors in family planning.
  406. Social marketing of contraceptives.
  407. Social marketing: the family planning experience.
  408. Social security and family planning.
  409. Social studies on fertility and contraception in Alexandria.
  410. The social worker and family planning.
  411. Socio-economic factors related to family planning communication.
  412. Socio-personal variables associated with people's attitude towards family planning.
  413. Sociological and psychological aspects of family planning.

     

  414. Sociological aspects of surgical contraception: the role of knowledge and attitudes.
  415. The sociological dimension of contraception. [La dimension sociologique de la contraception.]
  416. A sociological look at voluntarism in family planning.
  417. Solate, iron and total iron-binding capacity of the serum during hormonal contraception. Results of a prospective study. [Serumfolat, Serumeisen und totale Eisenbindungs-kapazitaet des Serums unter hormonaler Kontrazeption. Ergebnisse einer prospektiven Untersuchung.]
  418. Some aspects of planning and implementation of the family planning programme in Sri Lanka.
  419. Some effects of diet with oral contraceptives on carbohydrate: lipid metabolism in the baboon. (Abstract only)
  420. Some emerging issues in family planning administration.
  421. Some estimates of the potential reduction in the U.S. infant mortality rate by family planning. (Letter to the editor)
  422. Some ethical considerations in family planning programs.
  423. Some improvements in prescribing oral contraceptives as predicted by a computer simulation.
  424. Some legal aspects of semen storage and family planning programs.
  425. Some political and ethical problems in the development of family planning.
  426. Some practical applications of social psychology to family planning programs.
  427. Some principles for evaluative family planning research: a research-administrator's observations.
  428. Some psychological aspects of fertility, family planning and population policy in the United States.
  429. Some research needs of the national family planning program.
  430. Specific comments by the Board of Directors, Family Planning Association of British Columbia.
  431. Spectrum of bowel disease associated with use of oral contraceptives.
  432. Speculations about mortality trends from venous thromboembolic disease in England and Wales and their relation to the pattern or oral contraceptive usage.
  433. Speech by Mr. Chua Sian Chin, Minister for Health and Home Affairs at the opening ceremony of the National Seminar on Labour/Management Cooperation in Population and Family Planning Activities.
  434. Spirometry and oral contraceptives.
  435. St. Christopher/Nevis. (Family planning)
  436. St. Vincent (Family planning)
  437. State of hemodynamics of female internal sex organs in intrauterine contraception. [Sostoyanie gemodinamiki vnutrennikh polovykh organov zhenschin pri vnutrimatochnoi kontratseptsii.]
  438. State of the female genital organs during the use of polyethylene contraceptives. [Sostoyanie zhonskikh polovykh organov pri primenenii polietilenovykh vnu trimatochnykh kontratseptivov.]
  439. statement on the distribution and supervision of oral contraceptives.
  440. The status of maternal and child health practices among family planning acceptors and non-acceptors.
  441. The status of oral pill and I.U.C.D. (intra-uterine contraceptive device) in a National Programme.
  442. Status of women and family planning in a developing country -- Egypt.
  443. The status of women and family planning in Indonesia.
  444. Status of women and family planning.
  445. Sterilization as a method of birth control.
  446. Sterilization in relation to family planning.
  447. Sterilization procedures trends and considerations: draft report to the Committee on Maternal Health Care and Family Planning.
  448. Sterilization procedures: their role in national family planning program s.
  449. Steroid contraception and dysplasia of the cervix: an interim report.
  450. Steroid contraception.
  451. Steroid contraceptives: neuro-psychiatric and electroencephalographic complications.
  452. Steroid hormonal contraception.
  453. Stockholm to Cheltenham 1946-8. (Family planning)
  454. Strategies for the introduction of contraceptive methods: the Taiwan experience.
  455. Strategy and segmentation of the birth control market: this side of family planning.
  456. Strategy for contraceptive development.
  457. Strategy in contraceptive development.
  458. Streptococcal peritonitis in a patient with Hodgkin's disease and an intrauterine contraceptive device.
  459. Studies of carbohydrate and lipid metabolism in women developing hypertension on oral contraceptives.
  460. Studies of the effectiveness of temperature methods of family planning.
  461. Studies of tumorigenic and diabetogenic potential of certain oral contraceptive steroids in female dogs and monkeys. (Abstract only)
  462. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections, and contraception I. Venereal disease prophylaxis, past experience, present status and plans for future studies.
  463. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants.
  464. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 1) Diffusion of megestrol acetate in humans.
  465. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 3. Factors affecting steroid diffusion in vivo and in vitro.
  466. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
  467. Studies on uterine flushings in the baboon. 1. Method of collection, cellular composition, and protein electrophoretic profiles in animals with and without intrauterine contraceptive devices.
  468. Studies on uterine flushings in the baboon: 2. The effect of an intrauterine contraceptive device on certain biochemical parameters.
  469. A study of 2,245 women attending a hospital family planning clinic in Melbourne and the effect of the clinic on the hospital birth rate.
  470. A study of contraceptive effectiveness and incidence of side effects with the use of the Dalkon Shield.
  471. Study of family planning workers: a preliminary report.
  472. Study of folate status in long-term Egyptian users of oral contraceptive pills.
  473. Study of metabolism of circulating lipids during oral contraception. [Etude du metabolisme des lipides circulants sous oestro-progestatifs.]
  474. A study of one-hundred and sixty active and inactive family planning mothers and how they differ in attitudes and socio-economic conditions.
  475. A study of patient education in the family planning clinic at Grady.
  476. A study of physicians' attitudes towards induced abortion and contraceptives, Santiago, Chile.
  477. A study of repetitive recording of clients as new acceptors in the Malaysian family planning program.
  478. A study of the copper T intrauterine contraceptive device (TCu 200) in nulliparous women.
  479. A study of the indigenous methods of birth control.
  480. A study of the social costs and benefits of implementing a nationwide non-medical contraceptive social marketing program in Kenya.
  481. A study of two forms of contraception in general practice.
  482. A study of women attending the family planning clinic in the health unit Kurunegala.
  483. A study on amendment of the family law for rational implementation of family planning program in Korea.
  484. A study on family planning knowledge and attitudes of twenty-year old single males in Taiwan.
  485. Study on the interrelationship of the status of women and family planning: report of the special rapporteur.
  486. Sub-regional seminar on labour-management cooperation in population and family planning in the plantations industry.
  487. Success of randomization in a controlled contraceptive experiment.
  488. Successful family planning: Profamilia in Colombia.
  489. Summary of proceedings of the second seminar. (Family planning programs)
  490. Suppression of ovulation during the use of contraceptive pills. [Supresija ovulatsije kod primene kontratseptivnikh tableta.]
  491. Surgical sterilization of the woman - an alternative to legal abortion and contraceptives. [Steriliseringsoperation hos kvinnan - alternativ till legal abort och pr eventivmedel.]
  492. Surveillance summary: family planning services -- United States, 1971.
  493. Survey of contraceptive distribution in the national family planning program. [Panorama de la distribucion de anticonceptivos en el program nacional de planificacion familiar.]
  494. A survey of contraceptive practices and attitudes of unwed college students.
  495. A survey of family planning methods in general practice in Melbourne.
  496. Survey of health professionals regarding family planning.
  497. Survey of health professionals regarding family planning: preliminary report on nursing students and faculty.
  498. Survey of patterns of contraceptive distribution in Pakistan 1973.
  499. Survey of the clinical services of the national family planning program in Costa Rica. [Panorama de los servicios clinicos del programa nacional de planificacion familiar de Costa Rica.]
  500. A survey of the legal status of contraception, sterilization and abortion in European countries.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.